Bilaterale schwere Panuveitis während einer Krebsimmuntherapie mit Dabrafenib und Trametinib aufgrund einer okulären Toxoplasmose-Reaktivierung [Bilateral Severe Panuveitis Occurring during Cancer Immunotherapy with Dabrafenib and Trametinib Therapy Due to Toxoplasmosis Reactivation]
Details
Download: bilateral severe panuveitis Thieme 2023 10082023.pdf (224.20 [Ko])
State: Public
Version: Final published version
License: Not specified
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_396299C016B6
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Bilaterale schwere Panuveitis während einer Krebsimmuntherapie mit Dabrafenib und Trametinib aufgrund einer okulären Toxoplasmose-Reaktivierung [Bilateral Severe Panuveitis Occurring during Cancer Immunotherapy with Dabrafenib and Trametinib Therapy Due to Toxoplasmosis Reactivation]
Journal
Klinische Monatsblatter fur Augenheilkunde
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Publication state
Published
Issued date
04/2023
Peer-reviewed
Oui
Volume
240
Number
4
Pages
574-577
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Keywords
Humans, Melanoma/drug therapy, Skin Neoplasms/therapy, Immunotherapy/adverse effects, Panuveitis, Antineoplastic Combined Chemotherapy Protocols, Mutation
Pubmed
Web of science
Create date
15/05/2023 12:18
Last modification date
14/08/2023 6:09